SGIOF
Price
$12.28
Change
+$0.07 (+0.57%)
Updated
Jan 2 closing price
Capitalization
12.4B
SHWZ
Price
$0.01
Change
-$0.02 (-66.67%)
Updated
Jan 17 closing price
Capitalization
50.13M
67 days until earnings call
Ad is loading...

SGIOF vs SHWZ

Header iconSGIOF vs SHWZ Comparison
Open Charts SGIOF vs SHWZBanner chart's image
Shionogi & Co
Price$12.28
Change+$0.07 (+0.57%)
Volume$433
Capitalization12.4B
Medicine Man Technologies
Price$0.01
Change-$0.02 (-66.67%)
Volume$582
Capitalization50.13M
SGIOF vs SHWZ Comparison Chart
Loading...
View a ticker or compare two or three
VS
SGIOF vs. SHWZ commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGIOF is a Hold and SHWZ is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (SGIOF: $12.28)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGIOF’s FA Score shows that 2 FA rating(s) are green while.

  • SGIOF’s FA Score: 2 green, 3 red.

Price Growth

SGIOF (@Pharmaceuticals: Other) experienced а 0.00% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.23%. For the same industry, the average monthly price growth was +2.88%, and the average quarterly price growth was -9.56%.

Industries' Descriptions

@Pharmaceuticals: Other (+0.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
SGIOF($12.4B) has a higher market cap than SHWZ($50.1M). SHWZ has higher P/E ratio than SGIOF: SHWZ (14.66) vs SGIOF (9.57). SGIOF YTD gains are higher at: 0.573 vs. SHWZ (-50.000). SGIOF has higher annual earnings (EBITDA): 242B vs. SHWZ (73.6M). SGIOF has more cash in the bank: 563B vs. SHWZ (35.6M). SHWZ has less debt than SGIOF: SHWZ (154M) vs SGIOF (9.41B). SGIOF has higher revenues than SHWZ: SGIOF (427B) vs SHWZ (168M).
SGIOFSHWZSGIOF / SHWZ
Capitalization12.4B50.1M24,750%
EBITDA242B73.6M328,804%
Gain YTD0.573-50.000-1%
P/E Ratio9.5714.6665%
Revenue427B168M254,167%
Total Cash563B35.6M1,581,461%
Total Debt9.41B154M6,111%
FUNDAMENTALS RATINGS
SGIOF vs SHWZ: Fundamental Ratings
SGIOF
SHWZ
OUTLOOK RATING
1..100
3876
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
83
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
285
PRICE GROWTH RATING
1..100
8098
P/E GROWTH RATING
1..100
8676
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGIOF's Valuation (18) in the null industry is somewhat better than the same rating for SHWZ (83). This means that SGIOF’s stock grew somewhat faster than SHWZ’s over the last 12 months.

SGIOF's Profit vs Risk Rating (100) in the null industry is in the same range as SHWZ (100). This means that SGIOF’s stock grew similarly to SHWZ’s over the last 12 months.

SGIOF's SMR Rating (2) in the null industry is significantly better than the same rating for SHWZ (85). This means that SGIOF’s stock grew significantly faster than SHWZ’s over the last 12 months.

SGIOF's Price Growth Rating (80) in the null industry is in the same range as SHWZ (98). This means that SGIOF’s stock grew similarly to SHWZ’s over the last 12 months.

SHWZ's P/E Growth Rating (76) in the null industry is in the same range as SGIOF (86). This means that SHWZ’s stock grew similarly to SGIOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

SGIOF and

Correlation & Price change

A.I.dvisor tells us that SGIOF and ROMJF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGIOF and ROMJF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOF
1D Price
Change %
SGIOF100%
N/A
ROMJF - SGIOF
8%
Poorly correlated
N/A
TEVJF - SGIOF
8%
Poorly correlated
N/A
SFOSF - SGIOF
6%
Poorly correlated
N/A
RGEDF - SGIOF
3%
Poorly correlated
N/A
PCYN - SGIOF
1%
Poorly correlated
N/A
More

SHWZ and

Correlation & Price change

A.I.dvisor tells us that SHWZ and RSCI have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHWZ and RSCI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHWZ
1D Price
Change %
SHWZ100%
-66.67%
RSCI - SHWZ
10%
Poorly correlated
N/A
TCNNF - SHWZ
9%
Poorly correlated
+1.43%
SGIOF - SHWZ
8%
Poorly correlated
N/A
RAFA - SHWZ
8%
Poorly correlated
+1.32%
PHCUF - SHWZ
6%
Poorly correlated
N/A
More